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Genes uniquely regulated by the androgen receptor
(AR) typically contain multiple androgen response ele-
ments (AREs) that in isolation are of low DNA binding
affinity and transcriptional activity. However, specific
combinations of AREs in their native promoter context
result in highly cooperative DNA binding by AR and
high levels of transcriptional activation. We demon-
strate that the natural androgen-regulated promoters of
prostate specific antigen and probasin contain two
classes of AREs dictated by their primary nucleotide
sequence that function to mediate cooperativity. Class I
AR-binding sites display conventional guanine contacts.
Class II AR-binding sites have distinctive atypical se-
quence features and, upon binding to AR, the DNA struc-
ture is dramatically altered through allosteric interac-
tions with the receptor. Class II sites stabilize AR
binding to adjacent class I sites and result in synergistic
transcriptional activity and increased hormone sensi-
tivity. We have determined that the specific nucleotide
variation within the AR binding sites dictate differen-
tial functions to the receptor. We have identified the
role of individual nucleotides within class II sites and
predicted consensus sequences for class I and II sites.
Our data suggest that this may be a universal mecha-
nism by which AR achieved unique regulation of target
genes through complex allosteric interactions dictated
by primary binding sequences.
Despite intensive efforts investigating how the androgen
receptor (AR)1 uniquely regulates androgen-responsive pro-
moters, the fundamental mechanisms governing this specific-
ity are still not completely understood. The specificity of steroid
receptor response can arise through at least five stratified
regulatory mechanisms, including: availability of constituents
in the tissue such as hormones, corresponding receptors, and
transcriptional coregulator proteins; influence of proximal
transcription factors bound to the promoter; cooperative bind-
ing to multiple hormone response elements; and sequence-
specific DNA target recognition of individual binding sites (re-
viewed in Ref. 1). For the majority of nuclear receptors,
specificity of response is acquired largely by sequence specific-
ity of the primary DNA-binding site. This level of specificity is
commonplace with nuclear receptors within the thyroid, reti-
noid, estrogen receptor (ER) subfamily that bind as ho-
modimers and heterodimers as well as orphan receptors that
bind as monomers to distinctive extended DNA sequences (2–
7). Recently, evidence has emerged that steroid receptors can
also use sequence specificity to a degree to help discriminate
their binding targets (1, 8, 9). However, steroid receptors ap-
pear to often have overlapping sequence specificity within the
primary binding site and must employ additional mechanisms
to achieve exclusive regulation of their cognate regulated pro-
moters (10–12). In the case of AR, a number of studies have
shown that AR binds cooperatively to multiple androgen re-
sponsive elements (AREs) within native promoters, and this is
likely a fundamental mechanism for AR-specific transcrip-
tional activation (13–18).
By definition, cooperative DNA binding is the binding of a
protein at one DNA site that facilitates the binding of other
protein molecules at additional distant sites. This can occur by
stabilizing the binding of the resulting complex or by making
the additional binding sites more accessible (19–21). Stabiliza-
tion of a complex typically involves protein-protein interactions
and results in distant DNA sites brought together, looping out
the intervening DNA and resulting in an interactive cluster of
transcription factors. If cooperative binding involves creating
access to DNA sites, then it is normally achieved by allosteric
interactions between the protein and DNA, which alters the
DNA in a manner that either restricts the interaction of a
repressor complex or chromatin structure or permits the inter-
action of a positive acting factor (22–24). Examples of these
allosteric cooperative interactions have been well documented
for the structures of the NFAT1zFoszJunzARRE2, MAT alpha
2zMCM1zSTE6, and E1zE2 transcription regulatory complexes,
which reveal dramatic changes in protein conformation and
DNA bending upon complex formation (19–21). Typically, co-
operativity is studied between one species of protein that facil-
itates another protein species binding. However, in the case of
AR it is apparent that AR cooperates with other AR molecules
to bind to specific arrangements of multiple AREs within a
given promoter (9, 14, 15, 18).
The AR binds as a homodimer to individual inverted hexam-
eric DNA half-sites that are spaced by 3 base pairs. Studies
have shown that the highest affinity binding for AR and glu-
cocorticoid receptor (GR) occurs on the imperfect palindrome,
GGTACAnnnTGTTCT (1, 12). In nature, however, androgen-
regulated promoters do not contain this optimized element and
instead possess numerous variations of this consensus se-
quence (reviewed in Ref. 1). In general, these variants are of
lower affinity compared with the idealized element, but are
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instrumental in discriminating preferential steroid receptor
binding and transcriptional activation (1, 8, 9). Thus there is a
wide range of sequences that AR can bind, typically containing
the core requirement of three out of four guanines contacts at
GGTACAnnnTGTTCT. Sequence variation of the binding site
not only affects DNA binding affinity, but also separately af-
fects transcriptional activity in a manner that is discordant
with affinity (1).
By extrapolation of crystallographic studies of the GR DNA
binding domain (DBD) with DNA, it is assumed that AR uses
the same amino acids within its DNA recognition a-helix (CG-
SCKVFFKRAAE) to form similar hydrogen bonds to nucleo-
tides within the half-sites for sequence-specific recognition (25,
26). The most fundamental contacts obligatorily conserved
throughout the nuclear receptor family are between the first
lysine, which bonds to the second guanine GGTACA of the
half-site and the arginine, which binds to a conserved G base
paired to cytosine GGTACA (26–28). These anchoring base
contacts are universal within the nuclear receptor family and
have been demonstrated for a large number of receptors by a
variety of techniques (4, 29, 30). Further discrimination be-
tween half-sites is achieved by a specific van der Waals contact
between the valine and the thymidine base paired to A, GG-
TACA for AR, GR, and progesterone receptor (PR) (26–28). The
ER binds to an inverted repeat spaced by 3 base pairs with the
sequence, AGGTCAnnnTGACCT, by discrimination with its
DNA recognition a-helix (CEGCKAFFKRTIQ) using its unique
glutamate in a bond to cytosine base paired to the character-
istic guanine of an estrogen response element AGGTCA (31).
The alanine in the DNA recognition a-helix restricts ER from
binding to a sequence containing an AGGACA (7, 32, 33).
Although the core consensus half-sites extend for 6 base pairs,
other nucleotides are not known to engage in base-specific
bonds, but the conservation of these nucleotides imply func-
tional significance. Of interest is the observation that alter-
ation of the sixth nucleotide to a T or G increases transcrip-
tional activity despite lowering DNA binding affinity for AR
and PR (1, 34–36). In other studies, it has been shown that
particular nucleotides are discriminated against due to incom-
patibility of a receptor DBD structure and a given sequence,
which provides another level of discrimination (1, 7, 25, 37).
Therefore, there are general core nucleotide requirements of a
steroid response element, but there is also nucleotide variation
within the binding site that provides function apart from the
receptor binding affinity to the DNA.
AR DNA-binding sites display an exceptional amount of var-
iation in sequence and as isolated binding sites are typically of
relatively low affinity and low transcriptional activity. How-
ever, it is clear from studies with a number of promoters that
physiological levels of response by AR are achieved in conjunc-
tion with sets of AREs that are organized into the appropriate
spatial architecture (14, 17, 18). How these AREs interact
mechanistically in a cooperative manner for DNA binding and
in a synergistic manner for transactivation is not understood.
In this study we have identified and characterized the nature
and mechanism of cooperative binding of AR on androgen-
regulated regions of the probasin promoter and the PSA en-
hancer. We have identified and characterized a subclass of
AREs with distinctive sequence variation that AR binds in an
allosteric manner altering the local DNA structure. These sites
serve as a focal point that facilitates binding to adjacent AREs
of more conventional sequence identity. This stabilized com-
plex provides high levels of transcriptional activation by AR
and increased AR sensitivity to androgen concentration. This
phenomenon appears to be a universal mechanism by which
AR interacts cooperatively with DNA to enhance gene expres-
sion levels. This furthers our understanding of how androgen-
responsive genes are regulated and how the precise nucleotide
sequences AREs dictate unique functions.
EXPERIMENTAL PROCEDURES
Recombinant AR DNA Binding Domain Fusion Protein—The rat
AR-DBD (amino acids 524–648) was inserted into the EcoRI and
BamHI sites of pTrcHisC (Invitrogen, San Diego, CA) to construct the
six-histidine residue N-terminal fusion protein AR-HisTag. The recom-
binant protein was expressed in Escherichia coli JM109 and purified on
nickel-NTA-Sepharose according to the manufacturer’s instructions
(Qiagen Corp., Germany) except for the following modifications: the
column was washed once with 50 mM NaH2PO4, pH 8.0, 300 mM NaCl,
20 mM imidazole, and twice with 50 mM NaH2PO4 pH 8.0, 20 mM
imidazole. Protein was eluted off the Ni-NTA column with 20 mM Hepes
(pH 7.9), 100 mM KCl, 20% glycerol, 1 mM DTT, and 250 mM imidazole.
Protein concentrations were determined by Bradford Assays.
Full-length Androgen Receptor—Nuclear extracts were prepared
from HeLa cells containing the stable transfection FLAG tag full-length
androgen receptor (HeLa-fAR), a kind gift from Michael Carey, UCLA
(18). Cells were incubated 24 h in Dulbecco’s modified Eagle’s medium
containing 10% fetal bovine serum and 1 nM R1881 (PerkinElmer Life
Sciences) prior to extraction by a method modified from a previous
study (18). Briefly, cells were washed twice with phosphate-buffered
saline, harvested, and centrifuged 10 min at 1000 rpm. The cell pellet
was washed once with ice-cold phosphate-buffered saline and resus-
pended in 5 volumes of buffer A (10 mM HEPES, pH 7.9, 1.5 mM MgCl2,
10 mM KCl, 0.5 mM DTT), centrifuged 5 min at 1850 3 g and resus-
pended in 3 volumes of buffer A. After 10 min on ice the cells were
homogenized with 10 strokes in a Dounce homogenizer, and the nuclei
were pelleted by centrifugation for 15 min at 3300 3 g. Nuclei were
resuspended in 1 volume of buffer C (20 mM HEPES, pH 7.9, 25% v/v
glycerol, 20 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM phenyl-
methylsulfonyl fluoride, 0.5 mM DTT) and incubated at 4 °C for 30 min
with gentle mixing. The nuclear extract was obtained by centrifugation
at 21,000 3 g for 30 min.
Oligonucleotides—Fragments of the rat probasin promoter were gen-
erated by PCR amplification using the 2286 to 1 28 portion of the
probasin promoter inserted BamHI/HindIII into pBluescript (Strat-
agene, La Jolla, CA) as a template. The fragments studied are as
follows: ARE1 G-1 ARE2 G-2 (2269 to 277), G-1 ARE2 G-2 (2229 to
277), ARE1 G-1 (2269 to 2164), ARE2 G-2 (2150 to 277), ARE1(2269
to 2210), ARE2 (2150 to 2105), G-1(2229 to 2164), and G-2 (2121 to
277). In addition, six sets of complementary 29-mers corresponding to
the wild-type G-1 binding site and five mutant forms were synthesized:
wild-type G-1: 59-CTTATTAGGGACATACCCACAAAT-39; A195C: 59-C-
TTAATAGGGACATAAAGCCCCCAAATAA-39; C197T: 59-CTTAATAG-
GGACATAAAGCTCACAAATAA-39; G-207A: 59-CTTAATAGGAACAT-
AAAGCCCACAAATAA-39; T215G: 59-CGTAATAGGGACATAAAGCC-
CACAAATAA-39; Spacer mutant: 59-CTTAATAGGGACACGGAGCCC-
ACAAATAA-39. Oligonucleotides were synthesized by the Nucleic Acid
and Protein Services, University of British Columbia, Vancouver,
Canada.
DMS Methylation Protection and Methylation Interference—Methyl-
ation protection of either the rat probasin promoter and the human PSA
enhancer regions was performed by a modified protocol.2 In brief, his-
tidine-tagged AR-DBD (7.2 mg, 13.6 mM) was incubated at room tem-
perature with 2.0 mg of poly(dI-dC) (Amersham Pharmacia Biotech) and
DNA binding buffer (DBB: 20 mM HEPES, pH 7.9, 100 mM KCl, 10%
glycerol, 1 mM DTT). To each reaction 350,000 dpm (26.5 fmol) of
32P-single-end-labeled DNA probe was added, and the binding reaction
was brought to equilibrium at room temperature. To methylate the
protein-bound DNA probe, dimethyl sulfate (DMS) was added to a final
concentration of 19 mM and incubated at room temperature for exactly
2 min. The methylation process was stopped by loading the reaction
onto a 5% (29:1) polyacrylamide gel containing 0.53 TBE while it was
running at 16 V/cm at room temperature. DNA treated in the same
manner, but without AR-DBD added, was used as a control.
After separation by polyacrylamide gel electrophoresis, bands indi-
cating protein-bound and protein-free probes were excised and the DNA
was eluted. The methylated DNA was cleaved using 1 M piperidine, and
the denatured fragments were separated on a 6% (29:1) denaturing
polyacrylamide gel containing 13 TBE and 8.3 M urea. Gels were dried
and autoradiographed, and the developed images were scanned using a
Hewlett-Packard 6300-dpi resolution scanner. Bands were quantitated
2 Reid, K. J., and Nelson, C. C. (2001) Biotechniques 30, in press.
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and compared using ImageQuaNT (5.0). Methylation interference of the
G-1 and ARE2 fragments of the probasin promoter involved premethy-
lating the DNA fragments before carrying out the binding reaction. The
32P-single-end-labeled DNA probe (200 fmol) in DMS buffer (50 mM
sodium cacodylate, pH 8.0, 10 mM MgCl2, and 1.0 mg of calf thymus
DNA) was incubated with 45 mM DMS for exactly 2 min at room
temperature. The reaction was stopped with DMS Stop Solution (1.5
mM sodium acetate, pH 7.0, and 1.0 M b-mercaptoethanol), and the DNA
was ethanol-precipitated. The methylated probe was then used in a
protein-binding reaction with AR-DBD as described in the methylation
protection protocol. The bands indicating bound and free (in the pres-
ence of protein) and unbound (no protein) probes were excised, and the
DNA was eluted. The DNA was cleaved using 90 mM NaOH and exam-
ined as described in the methylation protection protocol.
Gel Mobility Shift Assays—For gel shift analysis of relative binding
affinities, radiolabeled fragments of the probasin promoter were ob-
tained by PCR amplification in the presence of a-dCTP (Amersham
Pharmacia Biotech) at 50 mCi/mmol specific activity. Probes were gel-
purified as described above. Binding assays were carried out by prein-
cubating AR-DBD-histidine tag protein (10 pmol) with 1 mg of poly(dI-
dC) and DBB in a 10-ml volume for 10 min. Increasing amounts of the
respective radiolabeled probe were then added in 2 ml of DBB and
incubated at room temperature for 10 min. Samples were then loaded
onto a 5% polyacrylamide gel and electrophoresed for 90 min at 20
V/cm. The gels were dried and autoradiographed on Biomax MR film
(Eastman Kodak Co.). For DNA binding analysis, bands corresponding
to the bound proteinzDNA complex and free DNA were excised from the
dried gel, and the activity of each band was determined by scintillation
counting. Relative binding affinity for the probes containing more than
one binding site (ARE1 G-1 ARE2 G-2, ARE1 G-1, and G-1 ARE2 G-2)
were compared by plotting bound versus free values averaged from
three independent repetitions for each probe. Binding constants for
probes containing one (dimeric) binding site (ARE1, G-1, ARE2, and
G-2) were determined by Scatchard analysis as described previously
(39).
Transcriptional Activation—Luciferase reporter plasmids were cre-
ated by introducing BamHI/HindIII ends to each fragment of the pro-
basin promoter by PCR and cloning into the corresponding restriction
sites of pTK-luc (ATCC). LNCaP cells were then transfected with 0.2 mg
of reporter plasmid, 1.2 mg of rat androgen receptor in pRcCMV (In-
vitrogen), and 8 ng of the renilla expression plasmid pRLTK (Promega)
using Lipofectin (Life Technologies). Cells were incubated for 22 h in
24-well plates containing either 5% charcoal-stripped medium alone or
with R1881 (PerkinElmer Life Sciences), ranging in concentration from
0.001 to 5 nM. Cells were washed and harvested with passive lysis
buffer (Promega). Luciferase activity of 20-ml aliquots of lysate was
determined using the Dual-Luciferase Reporter assay system (Pro-
mega) on a luminometer (Berthold, Germany). Luciferase activity was
normalized for transfection efficiency using renilla activity. Experi-
ments were done in triplicate, averaged, and expressed both in relative
luciferase units (RLU) and as -fold induction.
RESULTS
DMS Protection Reveals Atypical Androgen Receptor Binding
Sites—The AR has been shown to bind to the probasin pro-
moter in a highly cooperative manner (14). Two androgen re-
sponse elements (AREs) have been previously characterized in
the proximal promoter (15). These AREs, referred to as ARE1
and ARE2, are separated by 80 base pairs. If either ARE1 or
ARE2 is mutated to a nonbinding form, then binding to the
other ARE is impaired and transcriptional activity is greatly
compromised (15). In other data, in which the intervening
sequence has been deleted, transcription activation by AR is
greatly impaired (9). Therefore these data suggest that AR
binds cooperatively to the probasin promoter in a functionally
significant manner and that this cooperative binding is reliant
on the integrity of the intervening sequence (9). To investigate
the nature of AR’s interaction with the probasin promoter, we
employed chemical probe methodologies to investigate the
base-specific contacts of AR. To initiate these studies, we used
recombinant his-tagged purified AR-DBD extending from
amino acids 524 to 648 of the rat AR and DMS-based methyl-
ation interference (MeI) to examine the contacts made to gua-
nines by AR. In this methodology the DNA is premethylated
prior to binding to the protein of interest. If the methylation of
a specific guanine interferes with DNA binding, then the DNA
molecule segregates into the unbound or free fraction following
gel shift separation and is missing in the corresponding bound
fraction. On the other hand, if a methylated guanine does not
interfere with binding of the protein, then the DNA molecule
appears at equal concentrations in the bound and free frac-
tions. This methodology has been instrumental in indicating
DNA-protein contacts to guanines of many bimolecular inter-
actions. However, due to the cooperativity between AR-DBDs
bound to the multiple AREs on the probasin promoter, this
approach did not produce an interference pattern on the intact
promoter, whereas isolated AREs do show MeI patterns (data
not shown). This result is most likely, because the prevention of
one guanine contact was compensated for by contacts at addi-
tional sites and stabilized by protein-protein interactions, a
characteristic result we have found of MeI assays throughout
these studies when applied to highly cooperative binding sites.
Therefore, we turned to methylation protection (MeP)-based
assays in which the DNAzprotein complex is formed first and
then exposed to DMS to methylate guanines that are not in-
volved in hydrogen bonds with the protein.2 ProteinzDNA com-
plexes are then isolated by electrophoretic mobility shift assay,
the bound fraction is isolated and eluted, and methylation
patterns are analyzed on a denaturing gel in comparison to
control DNA that has not been bound by protein to improve the
sensitivity and specificity of DMS protection-based assays.2
DMS is an ideal chemical modifier probe, because it methylates
all guanines equally on free DNA and, therefore, the cleavage
patterns produce a uniform ladder of guanines within the se-
quence. Typically, this approach of MeP provides parallel in-
formation to MeI with respect to specific guanine contacts by
DNA binding proteins, because they are uniquely protected
from DMS attack when the protein is bound and noncontacted
guanines are methylated with the same efficiency as in the
unbound DNA control. However, if the DNA is locally distorted
by binding of a transcription factor, guanines can be hypersen-
sitive to DMS attack (40, 41).
The results from MeP assays of the intact probasin promoter
confirmed the previously identified ARE1 and ARE2 and illus-
trated the expected protection pattern of conserved guanine
contacts of the nuclear receptor superfamily with no change in
DMS sensitivity to the noncontacted guanine residues within
the binding sites (2241ATAGCAtctTGTTCT2227) and (2136AG-
TACTccaAGAACC2122) (Fig. 1). However, in addition to these
previously recognized binding sites of AR to the probasin pro-
moter, the DMS protection assays revealed two additional po-
tential AR binding sites with atypical half-site sequences lo-
cated at (2209 to 2196) and (2107 to 293). Most intriguingly,
these AR binding sites were unusual with respect to their
pattern of protected guanines and DMS hypersensitivity. To
resolve these complexes of AR-DBD binding to the probasin
promoter in more detail, we repeated the MeP assay using
smaller fragments of the probasin promoter extending from
(2269 to 2164) and (2229 to 277) (Fig. 2, a and b). These
higher resolution analyses demonstrated that the guanines in
the fifth position of the atypical half-sites were protected as to
be expected for nuclear receptor interaction with DNA
(2209GGGACAtaaAGCCCA2196) and (2107ATGACAcaaTGT-
CAA293). However, both of the atypical sites had guanines in
the third position of the presumed 59-half-sites that showed
dramatic DMS hypersensitivity and even more pronounced
DMS hypersensitivity in the 39-half-sites (2209GGGACAta-
aAGCCCA2196) and (2107ATGACAcaaTGTCAA293). Hypersen-
sitivity to DMS methylation is most commonly attributed to
structural alteration of the DNA, including strand displace-
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ment, kinking, and other forms of local DNA structure defor-
mation (42, 43). According to our understanding of the binding
of nuclear receptors to their response elements, the DNA is in
B-form and the guanine in the second location of the half-site
AGCCCA should be protected, not overtly hypersensitive (26,
28, 31, 44). The most striking consistent feature of these newly
identified AR-binding sites is that the hypersensitive guanines
are located in the position of the half-site that is a character-
istic discriminatory nucleotide within estrogen receptor (ER)-
responsive binding sites (2209GGGACAtaaAGCCCA2196) and
(2107ATGACAcaaTGTCAA293) (27, 31, 45, 46). However, the
conservation of the adenine adjacent to the guanine on these
binding sites prohibits interaction with ER (7, 32) (data not
shown). Interestingly, in a previous study of binding site selec-
tion, we have shown that a guanine at this location is preferred
for PR and equally preferable to the consensus thymidine for
AR (1).
Because of the unusual nature of these AR-binding sites
containing hypersensitive guanines in the third position of the
half-site, we have referred to these individual sites within the
probasin promoter as G-1 and G-2. The unusual binding pat-
terns of G-1 and G-2 with respect to DMS hypersensitivity have
lead us to classify these AR interactions as class II type binding
in contrast to the typical binding pattern hereafter called class
I type binding as demonstrated on ARE1 and ARE2.
Binding of Class II Sites Is Independent of Adjacent Class I
Sites—The apparent binding of the AR-DBD to the class II G-1
and G-2 sequences could be a function of weak interactions that
are buttressed by the two class I AR-DBD homodimers bound
to ARE1 and ARE2, respectively. If these AR dimers physically
interact in a cooperative manner, the intervening DNA must
assume a loop structure. Therefore, it is possible that the
interactions of class I AR dimers on ARE1 and ARE2 could
alter the DNA conformation such that further interactions of
the class I dimers to distant sites are permitted. This could
result in DNA torsional strain causing the guanine hypersen-
sitivity seen on the G-1 and G-2 regions. Alternatively, G-1 and
G-2 could be bound independently by two additional AR ho-
modimers and the hypersensitivity of these sequences may be
intrinsic to the nature of AR-DBD binding to this complex
promoter with four interacting sites. To distinguish between
these two possibilities the four individual binding elements
were tested in isolation for their ability to bind to AR. These
four individual fragments all bound AR-DBD and were each
further characterized for DNA binding affinity by Scatchard
analyses. These analyses were performed using a constant
amount of purified AR-DBD and increasing concentrations of
radiolabeled DNA in an electrophoretic mobility shift-based
assay to avoid inconsistencies caused by protein dilution over
large ranges of concentration. These data demonstrated that
the relative DNA binding affinities of the AR-DBD were 6.3 nM
for ARE2, 11 nM for ARE1, 14 nM for G-1, and 18 nM for G-2.
Although the isolated class I sites have slightly higher affinity
than the class II sites of the probasin promoter, all elements
displayed appreciable binding activity.
Because it was demonstrated that G-1 and G-2 were inde-
pendent binding sites of AR-DBD homodimers, we next wanted
to determine whether the DMS hypersensitivity seen on the
G-1 and G-2 elements was an intrinsic property of the individ-
ual G-1 and G-2 primary DNA sequence or if hypersensitivity
was a result of the multiple complex interactions in the context
of the promoter containing AREs interacting in a highly coop-
erative manner. Using the MeP assay as described above, it
was found that the relative pattern of protection and hypersen-
sitivity of AR binding to the isolated G-1 and G-2 elements was
highly similar to the pattern observed when this technique was
applied to the entire probasin promoter or its fragments (Fig.
3). Full-length flag-tagged AR prepared from a stably trans-
fected HeLa cell line also demonstrated the hypersensitive
pattern seen with the AR-DBD (data not shown) (18). To in-
vestigate further how the hypersensitive guanines were in-
volved in binding to the class II sites, we performed MeI in
which the DNA is premethylated as discussed above. In the
MeI analysis we found that the premethylation of the guanines
prevented binding by AR to both class I and class II binding
sites (Fig. 3). We interpret this intriguing set of findings to
mean that the guanines initially involved in hydrogen bonds
with AR in the recognition of the class II binding sites, as they
are in class I sites. However, after this initial recognition in-
teraction, there is an allosteric conformational change to the
class II binding sites in which the interaction with guanines is
altered and becomes hypersensitive to methylation. In sum-
mary, these results demonstrate that G-1 and G-2 can bind AR
independently, likely in an allosteric manner and that the
specific nucleotide sequence of these class II elements dictates
the hypersensitivity to guanine methylation within their
half-sites.
Class II Type Binding Sites Nucleate the Cooperative Binding
FIG. 1. The probasin reveals four AR-DBD-binding sites using
methylation protection assay. The AR-DBD was bound to the pro-
basin promoter (2269 to 277) and analyzed by DMS-based methylation
protection. Class I binding sites, ARE1 and ARE2, and class II binding
sites, G-1 and G-2, are illustrated with their sequences. Arrows indicate
half-site location and orientation. Open circles represent protected gua-
nines residues, whereas solid circles represent guanines hypersensitive
to DMS.
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to Adjacent Class I Sites—To investigate the functional role of
these class II binding sites in terms of cooperative binding by
AR to the probasin promoter, we created a series of DNA
fragments of various regions of the promoter containing com-
binations of ARE1, G-1, ARE2, and G-2 in their native context.
We analyzed combinations of the class I and class II elements
to determine the relative contribution of individual binding
sites to cooperativity as judged by complex formation as a
function of increasing DNA concentration as was performed
above for singular elements (Fig. 4) (39). These analyses re-
vealed that the combination of ARE1 and G-1 (with Kd values
of 11 and 14 nM in isolation, respectively) resulted in a cooper-
ative interaction that half-saturated the DNA at more than a
10-fold lower concentration (0.9 nM). Similarly ARE2 and G-2
interacted in a cooperative manner to shift the rate of complex
formation approximately an order of magnitude lower in con-
centration. The promoter fragment containing G-1, ARE2, and
G-2 interacted with the highest degree of DNA binding coop-
erativity resulting in half-saturated binding at 0.11 nM, which
is over 50 times stronger binding than ARE2, the individual
element with the highest DNA binding affinity. Interestingly,
the addition of ARE1 to this extremely cooperative DNA frag-
ment of G-1, ARE2, and G-2 resulted in weakening the overall
strength of the DNA binding complex with all four sites occu-
pied to ;1.2 nM to achieve half saturation. Comparable binding
results were observed with increasing AR-DBD protein concen-
tration in the presence of a constant amount of DNA. In thor-
ough examination of AR binding to this promoter containing all
four binding sites, it was apparent that the binding curve was
biphasic. The order of complex formation appears to be occu-
pation of G1-ARE2-G2 at low concentrations of protein, fol-
lowed by additional binding to ARE1 as protein concentration
increases. These results indicate that class II elements are
instrumental in providing the dramatic level of DNA binding
cooperativity seen on the probasin promoter. It is also clear
that the four individual elements interact in a complex manner
in which G-1 can interact individually with ARE1 or ARE2-G2.
However, if both ARE1 and ARE2-G2 are present on the same
DNA fragment, then the interaction between G-1 and ARE2-G2
is weakened, presumably, through an interaction with ARE1,
thereby affecting the overall stability of the complex.
Contribution of Class I and Class II Sites to Transcriptional
Activation on the Probasin Promoter—To determine whether
class II AR-binding sites contribute to the transcriptional ac-
tivity of the probasin promoter in response to hormone induc-
tion, we tested combinations of ARE1, G-1, ARE2, and G-2 as
well as the individual class I and class II elements for trans-
activation potential in the presence of increasing concentra-
tions of the synthetic androgen R1881 in LNCaP cells. All
individual class I and class II sites displayed low levels of
transcriptional activity (less than 2000 RLUs) that were max-
imal at 0.5 nM R1881corresponding to levels of 12-, 23-, 25-, and
33-fold, for G-1, ARE1, G-2, and ARE2, respectively (Fig. 5a).
Combining class I and II sites resulted in an increase in the
sensitivity to hormone concentration maximal at ;0.05 nM
R1881, but the magnitude of transcriptional activation of
ARE1-G1 and ARE2-G2 was at most additive of the activity of
the individual elements (Fig. 5b). The addition of G-1 to the
ARE2-G2 binding element resulted in dramatic synergistic
transcriptional activation to a maximum of 169-fold induction
FIG. 2. Pronounced DMS hypersensitivity in the 5*- and 3*-half-sites of class II AR-binding sites on the probasin promoter. The
probasin promoter fragments from (2269 to 2164) and (2181 to 277) were bound by AR-DBD and assayed by methylation protection. Arrows
indicate half-site orientation and location. Open circles represent protected guanines, and solid circles represent hypersensitive guanines. A, class
I binding element, ARE1, and class II binding element, G-1, are illustrated with their nucleotide sequence. B, class I binding element, ARE2, and
class II binding element, G-2, are illustrated with their nucleotide sequence.
Two Distinct Classes of Androgen Receptor DNA-binding Sites 2947
 at Queensland Univ of Technology (CAUL) on M
ay 14, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
(;20,000 RLUs), consistent with the increase in DNA binding
cooperativity when G-1 is combined with ARE2-G2 (Fig. 5c).
The addition of ARE1 to the highly cooperative DNA binding
region containing G-1, ARE2, and G-2 resulted in a biphasic
curve from 0.01 to 0.05 nM followed by a sharp increase in level
of activation to culminate in a 5-fold enhanced transcriptional
response (;100,000 RLUs) compared with G-1-ARE2-G2 alone
and more than 30-fold greater than any individual element
(Fig. 5c).
The higher relative transcriptional activity of ARE1-G1-
ARE2-G2 is in contrast to the cooperative binding data, which
demonstrated that the addition of ARE1 decreased the overall
binding strength of the complex. Together these data suggest
that a biphasic curve of activity arises from the highly cooper-
ative DNA binding complex at low concentrations of R1881,
presumably corresponding to concentration of activated AR in
the nucleus, whereas, at high levels of R1881 (activated AR),
the inclusion of ARE1 is able to provide highly synergistic
levels of transcriptional activation. In summary, these data
suggest that unique combinations of class I and class II sites
are required for maximal transcriptional activation by AR and
that each class I and class II element plays a unique functional
role in transcriptional activation, DNA affinity, and complex
stability that in a composite fashion culminates in a high level
of transcriptional induction. Furthermore, these results illus-
trate that androgen-regulated promoters can respond in a rhe-
ostat fashion to hormone concentration generally reflecting the
degree of cooperative DNA binding to the given promoter.
Characterization of class II Binding Sites of AR on the PSA
Enhancer—The AR has been reported to bind cooperatively to
a number of androgen-regulated promoters (9, 17, 18, 38). To
determine whether the principles of class I and class II AR
binding sites that we have documented for the probasin pro-
moter also applied to other cooperative promoters, we investi-
gated the characteristics of AR binding to the PSA enhancer.
This enhancer has recently been characterized in detail, iden-
tifying four AR binding sites, referred to in the earlier study as
V, IV, III, and IIIa, which interact in a cooperative manner, and
each site contributes to full androgen induction (18). To deter-
mine whether this cooperatively bound enhancer of the PSA
gene contained class II binding sites for the AR, we used DMS
protection assays as described for the probasin promoter. This
analysis demonstrated that two of the previously characterized
AREs, V, and IIIa, within the PSA enhancer had the same
distinctive features of hypersensitivity reported above for the
probasin promoter (Fig. 6). The high affinity PSA enhancer site
III was similar to a class I element. The PSA element, IV, was
similar to the class II sites but does not possess enough gua-
nines to confidently classify this element. From this analysis of
the PSA enhancer it was evident that additional guanines
immediately flanking the half-sites present only in the PSA
enhancer sequence showed hypersensitivity to DMS. There-
fore, this analysis provides additional information that the
structural distortion induced by AR binding to these class II
sites may extend over an area of at least 17 base pairs.
Consensus Sequence for Hypersensitive class II Sites of
AR—To determine the consensus features of class II binding
sites of AR, the elements that displayed the characteristic
hypersensitive guanines within the probasin promoter and
PSA enhancer were aligned to identify similarities. The num-
bering scheme for this analysis refers to the reference strand
with the base location indicated in reference to the central
nucleotide of the palindrome as 0 and ascending toward the
39-half-site and descending toward the 59-half-site (Fig. 7). This
comparison of AR-binding sites within the PSA enhancer and
probasin promoter derived a unique consensus of distinctive
features that distinguish class I and class II sites. Both class I
and II sites have a Cys at 23 and a Gly at 13. Class II sites
uniquely have a Gly at 25 and a Cys at 14 and/or 15. The most
prominent feature of class II sites is a purine at 17, which
displays a highly conserved pyrimidine in class I sites. Interest-
ingly, class II sites also contain a Tht at position 213 in all cases
and a corresponding Ala at 113 in all but one case. Additionally,
there is a tendency to have a higher AT-rich flanking region and
spacer in class II sites in comparison to class I sites.
FIG. 3. Class II binding elements demonstrate intrinsic DMS
hypersensitivity upon AR-DBD binding. Methylation protection
assays on individual class II AR-binding sites. Arrows denote half-site
orientation and location for each binding element sequence. Open cir-
cles represent protected guanines, whereas solid circles represent hy-
persensitive guanines. A, methylation protection of class II AR-binding
element G-1 contained within 2231 to 2164. B, methylation protection
of class II AR-binding element G-2 contained within 2128 to 256. C,
methylation interference assay demonstrates that conventional gua-
nine contacts are necessary for AR binding to G-1 and ARE2.
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Sequence Determinants for DMS-hypersensitive AR-binding
Sites—Because class II sites appeared to have distinctive con-
sensus nucleotides and demonstrated atypical AR binding pat-
terns in isolation, we next investigated the nucleotide determi-
nants of the class II sites that result in the allosteric structural
changes upon AR binding. To do so, we focused on the G-1
binding site from the probasin promoter using site-directed
mutagenesis followed by analysis of the DMS protection pat-
terns after binding of AR. The distinctive features of the class
II type binding sites in comparison to class I sites, other than
the aforementioned guanines in the third position of the half-
site, is that the spacer region was relatively AT-rich in com-
parison to class I type AREs. In addition it was noted that class
II sites had a Thr 6 base pairs 59 of each half-site and that in
the 39-half-site the sixth nucleotide was a purine in contrast to
the consensus pyrimidine in this location of class I sites. These
individual mutations were tested for their potential contribu-
tion to hypersensitivity as before (Fig. 8). The results from
DMS protection assays demonstrated that conversion of the
Thr at position 213, six bases 59 of the half-site, decreased the
guanine hypersensitivity in the 59-half-site but did not affect
the binding pattern of the 39-half-site. Likewise, conversion of
the half-site spacer nucleotides from TAA to CGG also de-
creased the hypersensitivity in the 59-half-site alone. When the
Ala at position 17 of the 39-half-site was converted to a Cys, the
DMS protection binding pattern of the 39-half-site reverted to
the pattern observed with a class I type binding site but did not
alter the hypersensitivity in the 59-half-site. Therefore, these
results suggest that class II type binding by AR is a composite
of influences, primarily distinguished by the nonconsensus pu-
rine nucleotide at the 17 position of the 39-half-site, but is also
influenced by the identity of other nucleotides in the flanking
and spacer regions.
In summary, these analyses clearly demonstrate that AR
binds to two structurally and functionally distinct classes of
AREs that are directed by allosteric interactions of the binding
complex. AR binding to class I sites have been previously rec-
ognized and use conventional nucleotide contacts used by most
nuclear receptors. These are of low DNA binding affinity and
transcriptional activity in isolation. In contrast, class II bind-
ing sites result in DNA structural alterations that display DMS
hypersensitivity to particular guanines expected to be con-
tacted, but are also of low affinity and transcriptional activa-
tion as individual elements. Unique combinations of class I and
class II sites result in dramatic cooperative DNA binding
affinity and a highly synergistic effect upon transcriptional
activity. This complex, composite function that facilitates
cooperative DNA binding and achieves a higher level of tran-
scriptional response is dictated by the primary nucleotide
sequence to which the AR binds.
FIG. 4. Class II AR-binding sites fa-
cilitate DNA cooperative binding on
the probasin promoter. Relative bind-
ing affinities of probasin promoter ele-
ments were determined by gel shift assay
using 5 nM purified His-tagged AR-DBD
with increasing concentrations of radiola-
beled DNA as indicated. Bound and free
fractions were isolated using a gel shift
assay, excised, and counted. The change
of the bound over free ratio is plotted as a
function of increasing input DNA. Only
values corresponding to the linear portion
of the binding curve are given. ARE1,
open circles; ARE2, filled circles; G1, open
squares; G2, filled squares; A1-G1, open
triangles; A2-G2, filled triangles; G1-A2-
G2, open diamonds; A1-G1-A2-G2, filled
diamonds.
FIG. 5. Class I and class II AR-binding sites display low levels
of transcriptional activity in isolation and interact synergisti-
cally in combination. a, transactivation activity of individual ele-
ments was tested in the presence of increasing concentrations of R1881.
ARE1 (open circles), ARE2 (filled circles), G-1 (open squares), and G-2
(filled squares). The boundaries of each site within the promoter are
indicated in Ref. 43. LNCaP cells transfected with pTK-luc reporter
plasmids containing the fragments were incubated 22 h with the indi-
cated concentration of R1881 then assayed for luciferase activity. Tran-
scriptional activity is reported as relative luciferase units (RLU) cor-
rected for background. b, effects on transactivation activity of
combining class I and class II AR binding sites of the probasin promoter
as assayed in A. Levels for ARE1-G1 (open triangles), ARE2-G2 (filled
triangles) are shown. c, transcriptional activity of multiple class I and
class II AR binding sites of the probasin promoter, G-1 ARE2 G-2
(closed diamonds) and ARE1 G-1 ARE2 G-2 (open diamonds) were
tested as described above.
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DISCUSSION
The AR can bind to a large repertoire of sequence variants
that resemble an inverted palindromic repeat spaced by 3 base
pairs. The sequence identity of the individual AR binding sites
within natural promoters may be incidental or may impart
function to the receptor response. In a previous analysis of AR
binding sites, we demonstrated that some of the nucleotide
variation within AR binding sites aid in discrimination of bind-
ing by GR and PR (1). Likewise, some nucleotide substitutions
within the binding site affected transcriptional activity in a
manner that was discordant with their effects on DNA binding
affinity (1, 34–36). Thus, the nucleotide sequence of an ARE
can separately function to help discriminate both preferential
steroid receptor binding and transcriptional activation. Our
previous study also provided evidence that AR binds to a nearly
palindromic DNA binding site in an asymmetrical manner that
extends 5 base pairs away from the previously recognized tar-
get. Together this suggests that AR binds to the DNA in an
allosteric manner and that the nucleotide sequence of the re-
sponse element imparts functional information to the AR-pro-
tein to which it is bound.
In the present study we have investigated the nature in
which AR binds cooperatively to multiple AREs within andro-
gen-regulated promoters. This study has led to the identifica-
tion of two distinct classes of AR binding sites. Class I sites
display conventional binding patterns in terms of guanine con-
tacts. Class II are distinguished by their unusual patterns of
hypersensitivity seen by DMS protection assays in response to
interaction with AR. Class II sites function to facilitate coop-
erative binding to adjacent class I sites, presumably through
local DNA structural alterations. Both class I and class II sites
in isolation are of low binding affinity and low transcriptional
FIG. 6. The PSA enhancer (24366 to 23874 bp) has three class II AR-binding sites as revealed by methylation protection analysis.
In all panels, open circles represent protected guanines, whereas solid circles represent hypersensitive guanines. Arrows denote half-site
orientation within each ARE. a, the AR-binding site III has a class I protection pattern, whereas AR-binding site V has similarity to class II type
protection/hypersensitive patterns. b, AR-binding site IIIA has a class II protection/hypersensitive pattern. c, the locations of the class I and class
II sites within the PSA enhancer sequence are indicated.
FIG. 7. Alignment of AREs into proposed class II and class I
AR-binding sites. ARE sequences from the probasin promoter, PSA
enhancer, PSA promoter, and Slp gene. Consensus features are high-
lighted by solid circles for class II and open circles for class I, with
conserved guanine contacts underlined. Italicized elements are pro-
posed by sequence similarity to the class designation.
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activity, requiring over 0.5 nM R1881 for full induction in tran-
sient transfection assays. Whereas, specific combinations of
class I and class II sites found in androgen-regulated promoters
synergistically increase DNA binding affinity, hormone sensi-
tivity, and levels of transcription in comparison to singular
AREs. The degree of DNA binding cooperativity most strongly
correlates to the high levels of transcriptional induction at very
low levels of hormone.
Summarizing the data obtained in this study and other stud-
ies of the probasin promoter, it is most likely that G-1, ARE2,
and G-2 interact cooperatively to increase the stability of the
DNA-binding complex and correspondingly are activated at
relatively low levels of hormone concentration. At higher levels
of androgens, this most highly cooperative complex for DNA
binding may be poised to stabilize binding of an additional AR
dimer to ARE1. The additional interaction with ARE1 de-
creases the physical stability of the overall complex, but pro-
vides maximal transcriptional activation.
Our working hypothesis is that the AR dimer bound to ARE1
may interact most efficiently with coregulator proteins to in-
duce androgen-dependent transcription from this promoter,
whereas ARE2 in this context is more integrally involved in
protein-protein interactions with AR molecules bound to G-1
and G-2. In the highly stable G-1zARE2zG-2 complex, the inter-
action site for AR coregulators of the three homodimers may be
less accessible. Therefore, when ARE1 is mutated, transcrip-
tional activity is lost possibly due to a lack of efficient coacti-
vator interactions with the remaining complex, whereas when
ARE2 is mutated, transcriptional activity is greatly decreased
due to impairment of DNA binding cooperativity (14). Thus
each of the four elements imparts a different function that
cumulates in a high level of transcriptional activity. In con-
trast, when these elements are bound by AR in isolation of
other AR sites, they exhibit a low level of transcriptional activ-
ity, and only at high levels of hormone, compared with the
highly cooperative DNA-binding complexes, which are acti-
vated at much lower concentrations of hormone. We interpret
this shift in the concentration of hormone induction to be a
function of titration of activated AR to the nucleus. Highly
cooperative AR complexes would require a correspondingly
lesser amount of activated AR for activation of transcription, as
paralleled by the cooperative DNA binding data. This study
demonstrates that the DNA-binding sites respond in a se-
quence- and concentration-dependent manner to the binding of
AR and that AR reacts differentially, in terms of function, to
binding DNA dependent upon the nucleotide sequence. This ev-
idence strongly suggests that the AR interaction with DNA is not
an inert binding process or docking station but is in fact mutually
allosteric in a functionally significant manner. This model gives
credence to the hypothesis that sequence variation of AREs is not
incidental in natural promoters, but imparts function to the
response to hormone induction in a complex composite manner.
In examination of other androgen-regulated promoters that
interact with the AR in a cooperative manner, we have identi-
fied putative class II binding sites, which suggests that this is
a universal mechanism by which the AR binds to multiple
AREs in a cooperative manner. In building on previous work
and the studies reported here we hypothesize that DNA se-
quence dictates function to the AR that is mediated by se-
quence-specific allosteric interactions. These mechanisms,
when used in combination, may provide for a rheostat of an-
drogenic response both in terms of amplitude and duration,
thereby allowing a specific gene to customize the transcrip-
tional response to a hormone stimulus in a promoter/gene-
specific fashion.
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